Annual Short Term Debt
$111.00 K
-$60.00 K-35.09%
31 December 2023
Summary:
ReShape Lifesciences annual short term debt is currently $111.00 thousand, with the most recent change of -$60.00 thousand (-35.09%) on 31 December 2023. During the last 3 years, it has fallen by -$3.81 million (-97.17%). RSLS annual short term debt is now -97.82% below its all-time high of $5.08 million, reached on 31 December 2007.RSLS Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$114.00 K
+$1000.00+0.88%
30 September 2024
Summary:
ReShape Lifesciences quarterly short term debt is currently $114.00 thousand, with the most recent change of +$1000.00 (+0.88%) on 30 September 2024. Over the past year, it has increased by +$4000.00 (+3.64%). RSLS quarterly short term debt is now -98.49% below its all-time high of $7.55 million, reached on 30 September 2009.RSLS Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RSLS Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.1% | +3.6% |
| 3 y3 years | -97.2% | -96.7% |
| 5 y5 years | +100.0% | -60.0% |
RSLS Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -97.2% | at low | -96.7% | +32.6% |
| 5 y | 5 years | -97.2% | -97.1% | +32.6% | |
| alltime | all time | -97.8% | -98.5% |
ReShape Lifesciences Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $114.00 K(+0.9%) |
| June 2024 | - | $113.00 K(+0.9%) |
| Mar 2024 | - | $112.00 K(+0.9%) |
| Dec 2023 | $111.00 K(-35.1%) | $111.00 K(+0.9%) |
| Sept 2023 | - | $110.00 K(+0.9%) |
| June 2023 | - | $109.00 K(+26.7%) |
| Mar 2023 | - | $86.00 K(-49.7%) |
| Dec 2022 | $171.00 K(-38.7%) | $171.00 K(-32.9%) |
| Sept 2022 | - | $255.00 K(-24.6%) |
| June 2022 | - | $338.00 K(-23.4%) |
| Mar 2022 | - | $441.00 K(+58.1%) |
| Dec 2021 | $279.00 K(-92.9%) | $279.00 K(-91.9%) |
| Sept 2021 | - | $3.44 M(-4.3%) |
| June 2021 | - | $3.60 M(+1025.0%) |
| Mar 2021 | - | $320.00 K(-91.8%) |
| Dec 2020 | $3.92 M(+1248.1%) | $3.92 M(+1169.6%) |
| Sept 2020 | - | $309.00 K(+2.0%) |
| June 2020 | - | $303.00 K(+2.0%) |
| Mar 2020 | - | $297.00 K(+2.1%) |
| Dec 2019 | $291.00 K(>+9900.0%) | $291.00 K(+2.1%) |
| Sept 2019 | - | $285.00 K(-16.9%) |
| June 2019 | - | $343.00 K(-81.7%) |
| Mar 2019 | - | $1.88 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2016 | - | $4.44 M(-31.8%) |
| June 2016 | - | $6.50 M(+15.3%) |
| Mar 2016 | - | $5.64 M(+686.1%) |
| Dec 2015 | $717.40 K(-75.9%) | $717.40 K(>+9900.0%) |
| Sept 2015 | - | $0.00(-100.0%) |
| June 2015 | - | $997.80 K(-49.9%) |
| Mar 2015 | - | $1.99 M(-33.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $2.98 M(-25.6%) | $2.98 M(-24.8%) |
| Sept 2014 | - | $3.96 M(-1.1%) |
| June 2014 | - | $4.00 M(0.0%) |
| Mar 2014 | - | $4.00 M(0.0%) |
| Dec 2013 | $4.00 M(+33.3%) | $4.00 M(0.0%) |
| Sept 2013 | - | $4.00 M(0.0%) |
| June 2013 | - | $4.00 M(0.0%) |
| Mar 2013 | - | $4.00 M(+33.3%) |
| Dec 2012 | $3.00 M(+30.0%) | $3.00 M(+50.0%) |
| Sept 2012 | - | $2.00 M(+100.0%) |
| June 2012 | - | $1.00 M(+428.3%) |
| Mar 2012 | - | $189.30 K(-91.8%) |
| Dec 2011 | $2.31 M(+150.2%) | $2.31 M(+1.6%) |
| Sept 2011 | - | $2.27 M(+34.4%) |
| June 2011 | - | $1.69 M(+51.1%) |
| Mar 2011 | - | $1.12 M(+21.3%) |
| Dec 2010 | $922.00 K(-76.2%) | $922.00 K(-46.3%) |
| Sept 2010 | - | $1.72 M(+52.0%) |
| June 2010 | - | $1.13 M(-71.8%) |
| Mar 2010 | - | $4.01 M(+3.3%) |
| Dec 2009 | $3.88 M(+45.1%) | $3.88 M(-48.6%) |
| Sept 2009 | - | $7.55 M(+2.8%) |
| June 2009 | - | $7.34 M(+80.2%) |
| Mar 2009 | - | $4.07 M(+52.3%) |
| Dec 2008 | $2.67 M(-47.4%) | $2.67 M(-32.2%) |
| Sept 2008 | - | $3.94 M(-9.2%) |
| June 2008 | - | $4.34 M(-6.4%) |
| Mar 2008 | - | $4.64 M(-8.7%) |
| Dec 2007 | $5.08 M(+91.6%) | $5.08 M(+15.4%) |
| Sept 2007 | - | $4.40 M(+66.0%) |
| Dec 2006 | $2.65 M(+165.6%) | $2.65 M(+165.6%) |
| Dec 2005 | $998.10 K | $998.10 K |
FAQ
- What is ReShape Lifesciences annual short term debt?
- What is the all time high annual short term debt for ReShape Lifesciences?
- What is ReShape Lifesciences annual short term debt year-on-year change?
- What is ReShape Lifesciences quarterly short term debt?
- What is the all time high quarterly short term debt for ReShape Lifesciences?
- What is ReShape Lifesciences quarterly short term debt year-on-year change?
What is ReShape Lifesciences annual short term debt?
The current annual short term debt of RSLS is $111.00 K
What is the all time high annual short term debt for ReShape Lifesciences?
ReShape Lifesciences all-time high annual short term debt is $5.08 M
What is ReShape Lifesciences annual short term debt year-on-year change?
Over the past year, RSLS annual short term debt has changed by -$60.00 K (-35.09%)
What is ReShape Lifesciences quarterly short term debt?
The current quarterly short term debt of RSLS is $114.00 K
What is the all time high quarterly short term debt for ReShape Lifesciences?
ReShape Lifesciences all-time high quarterly short term debt is $7.55 M
What is ReShape Lifesciences quarterly short term debt year-on-year change?
Over the past year, RSLS quarterly short term debt has changed by +$4000.00 (+3.64%)